Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study.
暂无分享,去创建一个
M. Rosenfeld | J. Davies | C. Wainwright | S. Cunningham | M. Higgins | C. Mckee | S. Tian | Linda T. Wang | D. Campbell | Jennifer Schneider